Clinical Trials Directory

Trials / Completed

CompletedNCT02891070

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated FS VH S/D 500 S-apr (Tisseel) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
224 (actual)
Sponsor
Baxter Healthcare Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery.

Conditions

Interventions

TypeNameDescription
DRUGFS VH S/D 500 s-apr
DEVICEDuraSeal Dural Sealant

Timeline

Start date
2016-10-11
Primary completion
2018-08-22
Completion
2018-08-22
First posted
2016-09-07
Last updated
2019-09-10
Results posted
2019-09-10

Locations

25 sites across 4 countries: United States, Czechia, Germany, Spain

Source: ClinicalTrials.gov record NCT02891070. Inclusion in this directory is not an endorsement.

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery (NCT02891070) · Clinical Trials Directory